Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 3;8(4):232.
doi: 10.3390/pharmacy8040232.

Stakeholders' Perceptions of Factors Influencing the Use of Take-Home-Naloxone

Taylor J Holland  1 , Jonathan Penm  1   2 , Jacinta Johnson  3 , Maria Sarantou  4 , Betty B Chaar  1
Affiliations
Review

Stakeholders' Perceptions of Factors Influencing the Use of Take-Home-Naloxone

Taylor J Holland et al. Pharmacy (Basel). .

Abstract

Background and aims: Opioid associated death and overdose is a growing burden in societies all over the world. In recent years, legislative changes have increased access to naloxone in the take-home setting for use by patients with a substance use disorder and bystanders, to prevent opioid overdose deaths. However, few studies have explored the factors influencing the uptake by its multiple stakeholders. The aim of this scoping review was to explore the factors influencing the use of take-home naloxone from the perspectives of different stakeholders.

Methods: A scoping review methodology was adopted with a systematic search of databases EMBASE, MEDLINE and PubMed. A variation of the search words "naloxone", "opioid" and "overdose" were used in each database. The articles were screened according to the predetermined inclusion/exclusion criteria and categorized based on their key perspective or target population.

Results: The initial database search yielded a total of 1483 articles. After a series of screening processes, 51 articles were included for analysis. Two key stakeholder perspectives emerged: patients and bystanders (n = 36), and healthcare professionals (n = 15). Within the patient and bystander group, a strong consensus arose that there were positive outcomes from increased access to take-home naloxone and relevant training programs. Despite these positive outcomes, some healthcare professionals were concerned that take-home naloxone would encourage high-risk opioid use.

Conclusion: Take-home naloxone is slowly being introduced into community practice, with a sense of enthusiasm from patients and bystanders. There are still a number of barriers that need to be addressed from healthcare professionals' perspective. Future research should be aimed at emergency care professionals outside of the US, who are most experienced with naloxone and its potential impact on the community.

Keywords: healthcare professional perspective; injecting drug users (IDUs); opioid; opioid antagonist; overdose; patients’ perspective; take-home naloxone.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Flow Diagram of Study Selection.
See this image and copyright information in PMC

References

    1. Roxburgh A., Ritter A., Slade T., Burns L. Trends in Drug Use and Related Harms in Australia, 2001 to 2013. National Drug and Alcohol Research Centre, University of New South Wales; Sydney, Australia: 2013. [(accessed on 8 June 2020)]. Available online: https://ndarc.med.unsw.edu.au/RESOURCE/TRENDS-DRUG-USE-AND-RELATED-HARMS....
    1. Roxburgh A., Burns L. Accidental Drug-Induced Deaths Due to Opioids in Australia, 2011. National Drug and Alcohol Research Centre; Sydney, Australia: 2015. [(accessed on 9 June 2020)]. Available online: https://ndarc.med.unsw.edu.au/resource/accidental-drug-induced-deaths-du....
    1. Bureau of Infrastructure, Transport and Regional Economics (BITRE) Road Deaths Australia, 2012 Statistical Summary. Department of Infrastructure and Transport; Canberra, Australia: 2013. [(accessed on 9 June 2020)]. Available online: https://bitre.gov.au/publications/ongoing/files/RDA_Summary_2012_June.pdf.
    1. Rintoul A.C., Dobbin D.M., Drummer O.H., Ozanne-Smith J. Increasing deaths involving oxycodone, Victoria, Australia, 2000–2009. Int. J. Prev. 2011;17:254. - PubMed
    1. Blanch B., Pearson S.A., Haber P.S. An overview of the patterns of prescription opioid use, costs and related harms in Australia. Br. J. Clin. Pharmacol. 2014;78:1159–1166. doi: 10.1111/bcp.12446. - DOI - PMC - PubMed

LinkOut - more resources